Head to Head Analysis: Novartis (NVS) vs. Its Competitors


Novartis is one of 104 public companies in the "Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Novartis to related companies based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk. Novartis pays an annual dividend of $2.30 per share and has a dividend yield of 2.7%.



from Biotech News